Initial Brazilian experience in the treatment of localized prostate cancer using a new generation cryotechnology: Feasibility study

International Braz J Urol

Volumn 38, Issue 5, 2012, Pages 620-626

  Kim, Fernando J ^a   Cerqueira, Michael A ^a,d   Almeida, Jose C ^b   Pompeo, Alexandre ^a,c   Sehrt, David ^a   Calheiros, Jose M ^b   Martins, Fernando A ^a,d   Molina, Wilson R ^a  

^a DENVER HEALTH MEDICAL CENTER   (United States)

^b Hospital das Forcas Armadas Brasilia   (Brazil)

^c FACULDADE DE MEDICINA DO ABC   (Brazil)

^d HOSPITAL BENEFICÊNCIA PORTUGUESA DE SÃO PAULO   (Brazil)

Author keywords

Cryoablation; Prostatic Neoplasms; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ARTICLE; BLOOD; BRAZIL; CANCER GRADING; CRYOSURGERY; FEASIBILITY STUDY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; REPRODUCIBILITY; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; BRAZIL; CRYOSURGERY; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84871579503     PISSN: 16775538     EISSN: 16776119     Source Type: Journal    
DOI: 10.1590/S1677-55382012000500006     Document Type: Article

References (33)

1. Katz AE, Rewcastle JC: The current and potential role of cryoablation as a primary therapy for localized prostate cancer. Curr OncolRep. 2003; 5: 231-8.
2. Cohen JK, Miller RJ: Thermal protection of urethra during cryosurgery of prostate. Cryobiology. 1994; 31: 313-6.
3. Hubosky SG, Fabrizio MD, Schellhammer PF, Barone BB, Tepera CM, Given RW: Single center experience with thirdgeneration cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life. J Endourol. 2007; 21: 1521-31.
4. Baust JG, Gage AA, Robilottto AT, Baust JM: The pathophysiology of thermoablation: optimizing cryoablation. Curr Opin Urol. 2009; 19: 127-32.
5. Cohen JK, Miller RJ, Shuman BA: Urethral warming catheter for use during cryoablation of the prostate. Urology. 1995; 45: 861-4.
6. Maccini M, Sehrt D, Pompeo A, Chicoli FA, Molina WR, Kim FJ: Biophysiologic considerations in cryoablation: a practical mechanistic molecular review. Int Braz J Urol. 2011; 37: 693-6.
7. Ismail M, Ahmed S, Kastner C, Davies J: Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int. 2007; 100: 760-4.
8. Cresswell J, Asterling S, Chaudhary M, Sheikh N, Greene D: Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int. 2006; 97: 969-74.
9. Dindo D, Demartines N, Clavien PA: Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240: 205-13.
10. Gonder MJ, Soanes WA, Smith V: Experimental prostate cryosurgery. Invest Urol. 1964; 1:610-9.
11. Onik G, Cobb C, Cohen J, Zabkar J, Porterfield B: US characteristics of frozen prostate. Radiology. 1988; 168: 629-31.
12. Onik GM, Cohen JK, Reyes GD, Rubinsky B, Chang Z, Baust J: Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993; 72: 1291-9.
13. Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, et al.: The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997; 157: 921-5.
14. Wong WS, Chinn DO, Chinn M, Chinn J, Tom WL, Tom WL: Cryosurgery as a treatment for prostate carcinoma: results and complications. Cancer. 1997; 79: 963-74.
15. Chin JL, Downey DB, Mulligan M, Fenster A: Three-dimensional transrectal ultrasound guided cryoablation for localized prostate cancer in nonsurgical candidates: a feasibility study and report of early results. J Urol. 1998; 159: 910-4.
16. Langenhuijsen JF, Broers EM, Vergunst H: Cryosurgery for prostate cancer: an update on clinical results of modern cryotechnology. Eur Urol. 2009; 55: 76-86.
17. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA, et al.: Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol. 2003; 170: 1126-30.
18. Ng CK, Moussa M, Downey DB, Chin JL: Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome. J Urol. 2007; 178: 1253-7; discussion 1257.
19. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M: Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology. 2002; 60: 3-11.
20. Polascik TJ, Nosnik I, Mayes JM, Mouraviev V: Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology. Urology. 2007; 70: 117-21.
21. Dall'Oglio MF, Crippo A, Faria EF, Carvalhal GF: Sociedade Brasileira de Urologia: Diretrizes de Cancer de Prostata. Rio de Janeiro, 2011; pp. 44.
22. Mouraviev V, Nosnik I, Sun L, Robertson CN, Walther P, Albala D, et al.: Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience. Urology. 2007; 69: 311-4.
23. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE: Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008; 180: 554-8.
24. El Hayek OR, Alfer W Jr, Reggio E, Pompeo AC, Arap S, Srougi M: Percutaneous prostate cryoablation as treatment for high-risk prostate cancer. Clinics (Sao Paulo). 2007; 62: 109-12.
25. Cohen JK, Miller RJ Jr, Ahmed S, Lotz MJ, Baust J: Ten-year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology. 2008; 71: 515-8.
26. Donnelly BJ, Saliken JC, Brasher PM, Ernst SD, Rewcastle JC, Lau H, et al.: A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer. Cancer. 2010; 116: 323-30.
27. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN Jr: Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology. 2001; 57: 518-23.
28. Asterling S, Greene DR: Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer. BJU Int. 2009; 103: 788-92.
29. Lambert EH, Bolte K, Masson P, Katz AE: Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007; 69: 1117-20.
30. Ellis DS, Manny TB Jr, Rewcastle JC: Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology. 2007; 69: 306-10.
31. Helgason AR, Adolfsson J, Dickman P, Fredrikson M, Arver S, Steineck G: Waning sexual function--the most important disease-specific distress for patients with prostate cancer. Br J Cancer. 1996; 73: 1417-21.
32. Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Leach GE, et al.: Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995; 273: 129-35.
33. Eton DT, Lepore SJ: Prostate cancer and health-related quality of life: a review of the literature. Psychooncology. 2002; 11: 307-26.